Leinco Technologies

Anti-Zolpidem - (Clone ZOL-2314)

Product Code:
 
LEI-Z102
Product Group:
 
Primary Antibodies
Host Type:
 
Mouse
Antibody Isotype:
 
Mouse IgG1 κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
ZOL-2314
Regulatory Status:
 
RUO
Shipping:
 
2 - 8°C Wet Ice
Storage:
 
This purified antibody is stable when stored at 2-8°C. Do not freeze.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-Z102-1.0mg1.0 mg£485.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Show All

Further Information

Concentration:
≥1.0 mg/ml
Formulation:
Formulated in 0.015M potassium phosphate buffered saline (0.85%), pH 7.2 and contains 0.05% sodium azide.
Product Description:
Zolpidem is a widely prescribed medication for the short-term treatment of insomnia. Introduced in the 1990s, zolpidem belongs to the class of sedative-hypnotic drugs known as non-benzodiazepine receptor agonists, specifically acting on the gamma-aminobutyric acid (GABA) type A receptors. By enhancing the inhibitory effects of GABA, zolpidem induces a calming effect on the central nervous system, promoting sleep initiation. While diagnostic testing for zolpidem is not common in routine clinical practice, there is a high potential for overuse and dependence when using this drug. Urine tests may be employed in cases of suspected misuse or overdose. The short half-life of zolpidem necessitates timely testing to detect its presence accurately. Clinicians may also consider diagnostic testing in situations where individuals exhibit unusual reactions or experience adverse effects, ensuring proper management of zolpidem use and promoting safe and effective treatment for insomnia.
Target:
Zolpidem